Westport: Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6
WESTPORT, Conn., Dec. 10, 2021 — Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to […]
Continue reading »